Inventor · disambiguated record
Jianming Bao
Also filed as: BAO JIANMING
40 granted patents·13 pending applications·447 citations·filing 1996–2024
97Inventor score
Top patents by PatentIndex Score
53 records- 0189US6809199B2(Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agentsMERCK & CO INC·Filed 2001·Granted Oct 26, 2004·47 cites·40 claims
- 0287US10329289B26,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptorBAO JIANMING·Filed 2016·Granted Jun 25, 2019·10 cites·20 claims
- 0386US9815846B2TrkA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2015·Granted Nov 14, 2017·8 cites·16 claims
- 0486US8124633B2Hydroxymethyl ether hydroisoindoline tachykinin receptor antagonistsDEVITA ROBERT J·Filed 2008·Granted Feb 28, 2012·16 cites·19 claims
- 0585US5696156ATriterpene derivatives with immunosuppressant activityMERCK & CO INC·Filed 1996·Granted Dec 9, 1997·36 cites·19 claims
- 0684US10933056B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2019·Granted Mar 2, 2021·2 cites·11 claims
- 0784US6489354B13-alkyl substituted pyrrolidine modulators of chemokine receptor activityMERCK & CO INC·Filed 2000·Granted Dec 3, 2002·15 cites·16 claims
- 0884US6051590AImmunosuppressant tricyclic compoundsMERCK & CO INC·Filed 1999·Granted Apr 18, 2000·29 cites·16 claims
- 0978US11149036B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorACTON III JOHN J·Filed 2018·Granted Oct 19, 2021·3 cites·18 claims
- 1078US5763478ATriterpene derivatives with immunosuppressant activityMERCK & CO INC·Filed 1996·Granted Jun 9, 1998·24 cites·19 claims
- 1177US6194458B1Benzamide potassium channel inhibitorsMERCK & CO INC·Filed 1999·Granted Feb 27, 2001·43 cites·19 claims
- 1276US6632836B1Carbocyclic potassium channel inhibitorsMERCK & CO INC·Filed 1999·Granted Oct 14, 2003·45 cites·23 claims
- 1376US6303593B13-thienyl and 3-furanyl pyrrolidine modulators of chemokine receptor activityMERCK & CO INC·Filed 2000·Granted Oct 16, 2001·8 cites·20 claims
- 1475US12428411B2Preparation of oxindole derivatives as novel diacylglyceride o-acyltransferase 2 inhibitorsMERCK SHARP & DOHME LLC·Filed 2024·Granted Sep 30, 2025·0 cites·26 claims
- 1575US6303637B1Heterocyclic potassium channel inhibitorsMERCK & CO INC·Filed 1999·Granted Oct 16, 2001·39 cites·11 claims
- 1674US10981902B25-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2018·Granted Apr 20, 2021·1 cites·18 claims
- 1773US7906503B2Substituted 3-alkyl and 3-alkenyl azetidine derivativesMERCK SHARP & DOHME·Filed 2008·Granted Mar 15, 2011·1 cites·14 claims
- 1871US8394969B2Cyclic benzimidazole derivatives useful as anti-diabetic agentsBOOKSER BRETT C·Filed 2009·Granted Mar 12, 2013·4 cites·19 claims
- 1970US5679705ATriterpene derivatives with immunosuppressant activityMERCK & CO INC·Filed 1996·Granted Oct 21, 1997·38 cites·19 claims
- 2069US12448384B2Diacylglyceride O-acyltransferase 2 inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Granted Oct 21, 2025·0 cites·29 claims
- 2169US8742110B2Spiroxazolidinone compoundsDUFFY JOSEPH L·Filed 2011·Granted Jun 3, 2014·3 cites·15 claims
- 2267US9717714B2Spirocyclic CETP inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Aug 1, 2017·1 cites·3 claims
- 2367US7485732B2Substituted 3-alkyl and 3-alkenyl azetidine derivativesMERCK & CO INC·Filed 2004·Granted Feb 3, 2009·2 cites·1 claims
- 2466US8329914B2Cyclic benzimidazole derivatives useful as anti-diabetic agentsBAO JIANMING·Filed 2009·Granted Dec 11, 2012·1 cites·17 claims
- 2565US6022890AImmunosuppressant tetracyclic triterpenesMERCK & CO INC·Filed 1998·Granted Feb 8, 2000·11 cites·15 claims
- 2665US5874594ATriterpene derivatives with immunosuppressant activityMERCK & CO INC·Filed 1997·Granted Feb 23, 1999·11 cites·16 claims
- 2764US12410159B2Preparation of oxindole derivatives as novel diacylglyceride O-acyltransferase 2 inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Sep 9, 2025·0 cites·48 claims
- 2864US8563746B2Cyclic benzimidazole derivatives useful as anti-diabetic agentsDANG QUN·Filed 2009·Granted Oct 22, 2013·1 cites·13 claims
- 2962US6372764B1Pyrrolidine modulators of chemokine receptor activityMERCK & CO INC·Filed 2000·Granted Apr 16, 2002·2 cites·16 claims
- 3061US5952371ATriterpene derivatives with immunosuppressant activityMERCK & CO INC·Filed 1997·Granted Sep 14, 1999·24 cites·9 claims
- 3157US2025099478A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 3253US12459927B2Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Nov 4, 2025·0 cites·16 claims
- 3353US2025122174A1Heteroaryl Compounds As HPK1 Inhibitors And Methods Of Using SameSHENZHEN YUANLI SHENWAN INNOVATIVE MEDICINE CO LTD·Filed 2023·Application pending·0 cites
- 3452US2025230159A1Fused heterocyclic compounds as modulators of ras signallingSHENZHEN IONOVA LIFE SCIENCE CO LTD·Filed 2023·Application pending·0 cites
- 3552US2024025917A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 3651US11976061B2Preparation of benzimidazolone derivatives as novel diacylglyceride O-acyltransferase 2 inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted May 7, 2024·0 cites·39 claims
- 3751US5998408ATriterpene derivatives with immunosuppressant activityMERCK & CO INC·Filed 1997·Granted Dec 7, 1999·14 cites·9 claims
- 3851US2023416227A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 3951US2024190892A1Plasma kallikrein inhibitorsCERNAKA NATALIJA·Filed 2022·Application pending·0 cites
- 4049US11970479B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 30, 2024·0 cites·18 claims
- 4148US2009286777A15,6,Fused Pyrrolidine Compounds Useful as Tachykinin Receptor AntagonistsBAO JIANMING·Filed 2007·Application pending·0 cites
- 4246US2010197724A16.5 -pyrrolopiperidine tachykinin receptor antagonistsBAO JIANMING·Filed 2008·Application pending·0 cites
- 4345US8410284B2Cyclic benzimidazole derivatives useful as anti-diabetic agentsDANG QUN·Filed 2009·Granted Apr 2, 2013·0 cites·17 claims
- 4444US11339156B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2018·Granted May 24, 2022·0 cites·11 claims
- 4544US5883119ATriterpene derivatives with immunosuppressant activityMERCK & CO INC·Filed 1996·Granted Mar 16, 1999·8 cites·15 claims
- 4643US2023219962A1PYRAZOLO[4,3-d]PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CELLULAR PROLIFERATIVE DISORDERSBAO JIANMING·Filed 2021·Application pending·0 cites
- 4742US2009042854A1Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor AntagonistsBAO JIANMING·Filed 2007·Application pending·0 cites
- 4842US2009048248A1Octahydropyrano[3,4-C]Pyrrole Tachykinin Receptor AntagonistsDEVITA ROBERT J·Filed 2006·Application pending·0 cites
- 4941US2008039494A18-Phenyl-5,6,7,8-Hydroquinoline Tachykinin Receptor AntagonistsBAO JIANMING·Filed 2005·Application pending·0 cites
- 5039US11319298B2Heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2017·Granted May 3, 2022·0 cites·20 claims
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jianming Bao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →